| Typicality: | 0.162 |
| Saliency: | 0.000 |
| for proprietary technology | 3 | purpose |
| to enhance cannabinoid bioavailability | 3 | purpose |
| emerald → secured → exclusive strategic partnerships | 3 |
| negative | neutral | positive |
| 0.002 | 0.322 | 0.676 |
| Raw frequency | 3 |
| Normalized frequency | 0.000 |
| Modifier score | 0.500 |
| Perplexity | 424.997 |